Gilead Sciences

GILD

76.510
USD
0.47
(0.62%)
Market Closed
Volume
250,879
EPS
0
Div Yield
0
P/E
105
Market Cap
107,430,366,669

Related Instruments

ABBV
4.380
(2.36%)
189.700 USD
AMGN
2.78
(0.84%)
335.22 USD
BMY
0.620
(1.30%)
48.180 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
PFE
0.115
(0.38%)
30.650 USD
REGN
13.14
(1.22%)
1,091.19 USD
SNY
-0.090
(-0.17%)
51.700 USD

News

Title: Gilead Sciences

Sector: Healthcare
Industry: Drug Manufacturers - General
Gilead Sciences Inc. is an American biopharmaceutical firm that was founded in 1987 under the name Oligogen by Michael L. Riordan. The company specializes in the research, development and sale of medicines in underdeveloped research areas. To this end, the company engages its research in such areas as the human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under many brand names, including Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Sovaldi and more. The company is headquartered in Foster, California, and its stock is measured on the NASDAQ Biotechnology Index and the S&P 500 Index.